19-Nor-5-androstenediol
Grundinformationen
- CAS
25975-59-1- Standard-SMILES
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@H]43)[C@@H]1CC[C@@H]2O- InChIKey
VVUQRXPUVKXAIO-XFUVECHXSA-N- Summenformel
- C18H28O2
- Durchschnittliche Molmasse
- 276,4 g/mol
- Monoisotopische Masse
- 276,20893014
Überblick
19-nor-5-androstenediol is a DEA Schedule III controlled substance. Substances in the DEA Schedule III have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. It is a Anabolic steroids substance.
Namen und Bezeichner
- Bevorzugter Name
- 19-Nor-5-androstenediol
- IUPAC
- (3S,8R,9S,10R,13S,14S,17S)-13-methyl-1,2,3,4,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol
- Englischer Name
- 5-ANDROSTENEDIOL
- Summenformel
- C18H28O2
- Molmasse
- 276.41
Namen und Synonyme
19-Nor-5-androstenediol19-Norandrostenediolestr-5-ene-3beta,17beta-diol25975-59-15N0V272KSAUNII-5N0V272KSA19-nor-5-androstene-3beta,17beta-diol5-NORENDIOLD5-Estrene-3b,17b-diolEstr-5-ene-3b,17b-diol19-NORJ1.680.819I
Weitere Namen anzeigen
ANDROSTENDIOLHERMAPHRODIOL5-ANDROSTENEDIOLNorandrostenediolANDROSTENEDIOL, 5-9-Nor-5-androstene-3β,17β-diol5-ANDROSTENE-3BETA,17BETA-DIOL19-Nor-5-androstene-3β,17β-diolEstr-5-ene-3,17-diol, (3β,17β)-
19-Nor-5-androstene-3b,17b-diol(3b,17b)-Estr-5-ene-3,17-diolESTR-5-ENE-3.BETA.,17.BETA.-DIOL3.ALPHA.,17.BETA.-DIHYDROXYESTR-5-ENE3.BET.A,17.BETA.-DIHYDROXYESTR-5-ENE19-NOR-5-ANDROSTENE-3.BETA.,17.BETA.-DIOL19-NOR-5-ANDROSTENE-3.BETA.O,17.BETA.-DIOLRefChem:79521
Datenbank-Bezeichner
- CAS
25975-59-1- PubChem CID
- 9900246
- DTXSID
DTXSID70703096- ChEMBL
CHEMBL259126- UNII
- 5N0V272KSA
- Nikkaji
- J1.680.819I
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,8
- Polarare Oberfläche (TPSA)
- 40,5 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 20
- Formalladung
- 0
- Komplexität
- 429
Experimentelle und physikochemische Eigenschaften
Drugs
DEA NFLIS-Drug Category -> Steroids
DEA Schedule III Controlled Substance -> Anabolic steroids
Pharmaceuticals -> Listed in ZINC15
LipidsLipids -> Sterol Lipids [ST] -> Steroids [ST02] -> C18 steroids (estrogens) and derivatives [ST0201]
Endocrine DisruptorsPotential endocrine disrupting compound
Physical DescriptionSolid
Physikochemische Eigenschaften
- Schmelzpunkt
- 152 · 152-157 °C(Solv: ethanol, 95% (64-17-5))
- Siedepunkt
- 429.2 · 429.2±45.0 °C(Predicted)
- Dichte
- 1.14 · 1.14±0.1 g/cm3(Predicted)
- Löslichkeit
- Chloroform (Very Slightly, Sonicated), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 15 · 15.00±0.60(Predicted)
- Farbe
- White to Off-White
Sicherheit und Regulatorisches
Gefahrenhinweise
Regulatory InformationDEA schedule III controlled substance
Sicherheitsdaten
- hs_code
- 29061990
- DEA Controlled Substances
- CSCN: 4000CSA SCH: Schedule IIINARC: No
Chemie und Industrie
Pharmakologische Informationen
Cellular LocationsExtracellular
Anwendungen
Verwenden9-Nor-5-androstene-3β,17β-diol is a synthetic anabolic steroid that interacts with androgen receptors. 9-Nor-5-androstene-3β,17β-diol has been studied as a new C19-steroidal androgen receptor modulato rs for potential treatment of prostate cancer.
Anbieter3 Anbieter
艾吉析科技（上海）有限公司17717235263 · [email protected]
艾吉析科技（上海）有限公司17721401538;17717235263 17721401538 · [email protected]
重庆卡兰医药有限公司[email protected]
Zugehörige Reaktionen
1
Notizen zur Verbindung
Wird geladen…